John Barry joined Pharm-Olam in 2017 and serves as the chief operating officer. In this role, Mr. Barry is responsible for the executive oversight of the daily operations of Pharm-Olam’s clinical operations, data management, statistics and medical writing services.
Mr. Barry has extensive experience in the drug development industry and has worked as an executive leader in a variety of functions including alliance management, business development, clinical operations, contracts, proposals and legal. Prior to joining Pharm-Olam, Mr. Barry was the head of portfolio sourcing and relationship management and a member of the senior leadership team for Merck Research Laboratories’ Global Clinical Trials Organization.
He has managed a variety of delivery models including functional, full-service CRO, single service and sole source relationships. He is well versed across a variety of contract structures including value-based contracting and has significant experience negotiating innovative commercial and capital models.
Prior to joining Merck, Mr. Barry spent over 20 years working for two of the top five global CROs. Mr. Barry has a bachelor’s of science degree from Cornell University and an MBA from the University of North Carolina at Chapel Hill.